Skip to content
Drug recall · FDA · Published July 29, 2019

Upsher Smith Laboratories, Inc. recalls Bexarotene Capsules, 75 mg, 100 capsules per bottle, Rx Only, Manufactured for: Upsher-Smith Laboratories, LLC, Maple

Upsher Smith recalls 75mg Bexarotene Capsules due to failed dissolution specifications. Rx-only capsules may not release medication properly. Contact for return instructions.

🇺🇸 FDA recall #D-1836-2019DrugUpsher Smith ›
Take action

Contact the company & request your remedy

Recalling firmUpsher Smith Laboratories, Inc.6701 Evenstad Dr N, N/A · Maple Grove, MN 55369-6026
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

Upsher Smith is recalling 75 mg Bexarotene Capsules (Rx only) because they failed dissolution specifications. This means the capsules may not release medication properly as intended, potentially affecting treatment effectiveness. Read more at govinfonow.com/recall/38200-upsher-smith-bexarotene-capsules-recall-failed-dissolution-specifications.

Source Summary by GovInfoNow · govinfonow.com/recall/38200-upsher-smith-bexarotene-capsules-recall-failed-dissolution-specifications · Updated October 5, 2026 · FDA enforcement record: FDA #D-1836-2019

Cite this page

“Upsher Smith Bexarotene Capsules Recall: Failed Dissolution Specifications.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38200-upsher-smith-bexarotene-capsules-recall-failed-dissolution-specifications. Based on FDA recall #D-1836-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1836-2019%22&limit=1).

Why it’s dangerous

The capsules failed to dissolve properly as required, meaning they may not release medication correctly. This could lead to inconsistent drug delivery and treatment effectiveness. However, the recall does not indicate immediate safety risks like injury or death.

Who’s affected

Prescription patients using Bexarotene Capsules for specific medical conditions. Those with the NDC code 0832-0285-00 and lot number A2610 are most at risk.

How to tell if you have this one

Check for the product name 'Bexarotene Capsules', 75 mg, 100 capsules per bottle, Rx only. Look for NDC code 0832-0285-00 and lot number A2610 on the packaging.

  • Brand
    Upsher Smith
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the product name, strength, and packaging details to confirm if it matches the recalled items.

  2. Contact Manufacturer

    Reach out to Upsher Smith Laboratories for specific return or disposal instructions.

✎ GovInfoNow

Questions people ask

Why is this product being recalled?

The capsules failed dissolution specifications, meaning they may not release medication properly as intended.

What should I do if I have this product?

Contact Upsher Smith Laboratories for specific return or disposal instructions.

Is there a risk of serious injury from this product?

The recall does not indicate any immediate safety risks like injury or death; the primary concern is treatment effectiveness.

Take action

Contact Upsher Smith

We’ve drafted a message you can send Upsher Smith to request your refund or repair — edit it as you like.

Subject: Recall D-1836-2019 — Upsher Smith Upsher Smith

Hello,

I own a Upsher Smith that is covered by recall D-1836-2019 from Upsher Smith.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1836-2019 (July 29, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1836-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA